SCHEMBL16620534

SCHEMBL16620534

O=C(Nc1ccc(CN2CCC2)c(F)c1)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPY2R P49146 1/20 0.47
CNR2 P34972 2/20 0.46
CNR1 P21554 1/20 0.46
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 2/20 0.44
GLA P06280 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.43
HRH3 Q9Y5N1 2/20 0.42
GAA P10253 1/20 0.42
DCUN1D1 Q96GG9 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929396 0.86 KIT (0.52)
SCHEMBL3166509 0.82 KIT (0.51) SMN1; SMN2
SCHEMBL16620023 0.77 CYP1A2 (0.48) SMN1; SMN2MAPTGAACYP1A2CYP2C9
SCHEMBL7008043 0.75 KDM4E (0.67) KDM4ESMN1; SMN2ALDH1A1HRH3GAA
SCHEMBL4933270 0.75 KIT (0.65)
SCHEMBL16620422 0.75 EPHX2 (0.54) SMN1; SMN2NPY2RCYP2C9CYP2C19MEN1
SCHEMBL3182950 0.75 RET (0.63) MAPK1HTT
SCHEMBL14818472 0.74 KDM4E (0.49) KDM4ESMN1; SMN2NPY2RMAPK1ALDH1A1
SCHEMBL14801861 0.74 AR (0.54)
SCHEMBL25245565 0.74 LMNA (0.56) KDM4EALDH1A1MAPTMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed